|
Zinc dysregulation as a druggable target in human skin photocarcinogenesis
|
1R03CA230949-01
|
$73,677
|
|
WONDRAK, GEORG
|
UNIVERSITY OF ARIZONA
|
|
Womens Interagency HIV Study (WIHS-V)
|
3U01AI035004-25S1
|
$144,370
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
WIHS Data Management and Analysis Center (WDMAC)
|
3U01AI042590-20S1
|
$95,311
|
|
GANGE, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
WEE1 inhibition and tumor immunity
|
1R01CA222963-01A1
|
$446,500
|
|
ZHANG, BIN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Water Soluble Polymers to Target Tumor-Associated Extracellular Matrix for Delivery of MMP Inhibitors
|
5F31CA213901-02
|
$44,524
|
|
SUBRAHMANYAM, NITHYA
|
UNIVERSITY OF UTAH
|
|
Vitamin D Deficiency Leads to Increased Intra-Prostatic Androgens in African American Men
|
1R21CA231610-01
|
$208,670
|
|
NONN, LARISA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Vitamin D and HA Signaling in TNBC
|
3R01CA194500-04S1
|
$51,381
|
|
WELSH, JOELLEN
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
Vitamin D and HA Signaling in TNBC
|
3R01CA194500-04S2
|
$57,310
|
|
WELSH, JOELLEN
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
Vitamin D and colorectal cancer risk: an integrated molecular and genetic epidemiologic study
|
4R00CA207848-03
|
$19,074
|
|
WARREN ANDERSEN, SHANEDA
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
3R01CA184456-03S2
|
$65,611
|
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Validating and targeting USP35 for anticancer drug development
|
1U01CA222958-01A1
|
$349,766
|
|
LIU, CHANGWEI
|
UNIVERSITY OF COLORADO DENVER
|
|
Utilizing Nucleic-Acid Scavengers to Ameliorate Inflammation-driven Metastatic Progression in Breast Cancer
|
1F31CA232394-01
|
$35,885
|
|
ETESHOLA, ELIAS
|
DUKE UNIVERSITY
|
|
Using patient-derived models to understand drug responses in SCLC
|
1U01CA220323-01A1
|
$619,923
|
|
DYSON, NICHOLAS
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Using mobile technology to understand the impact of socioeconomic and neighborhood factors on smoking cessation
|
1F32CA232796-01
|
$58,282
|
|
CAMBRON, CHRISTOPHER
|
UNIVERSITY OF UTAH
|
|
Using Functional Genomics to Inform Gene Environment Interactions for Colorectal Cancer
|
3R01CA201407-02S1
|
$32,686
|
|
PETERS, ULRIKE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Using Community-Engaged Methods to Design a Tool to Promote Informed Breast Cancer Screening Decisions for Low Literacy Women
|
1K07CA221899-01A1
|
$129,704
|
|
GUNN, CHRISTINE
|
BOSTON MEDICAL CENTER
|
|
Using a Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening
|
1R01CA222090-01A1
|
$558,179
|
|
CARTER-HARRIS, LISA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Unraveling the Complexities of Risk and Mechanism in Cancer
|
1R35CA220523-01A1
|
$978,294
|
|
QUACKENBUSH, JOHN
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S1
|
$113,625
|
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S2
|
$60,000
|
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S3
|
$250,001
|
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S1
|
$629,550
|
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
Understanding Wnt5a regulation of protein depalmitoylation during cell migration
|
3R01CA181633-05S1
|
$69,420
|
|
WITZE, ERIC
|
UNIVERSITY OF PENNSYLVANIA
|
|
Understanding tumor addiction to TRK fusions and sensitivity to TRK inhibition
|
1R01CA226864-01A1
|
$607,184
|
|
SCALTRITI, MAURIZIO
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Understanding sex differences in colon cancer metabolism
|
1R21CA223686-01A1
|
$182,156
|
|
JOHNSON, CAROLINE
|
YALE UNIVERSITY
|
|
Understanding how patient-derived resistance mutations affect the process of imatinib binding to Abl kinase
|
1F30CA225172-01A1
|
$32,574
|
|
LYCZEK, AGATHA
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Understanding and predicting relapse in acute myeloid leukemia
|
2R01CA175008-06
|
$418,000
|
|
RADICH, JERALD
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Uncovering Mechanisms of Regulation and Dependency on Fatty Acid Oxidation in MYC-Driven Tumors
|
1R01CA223817-01A1
|
$366,000
|
|
GOGA, ANDREI
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Uncovering Genotype Specific Vulnerabilities in KRAS Mutant Lung Cancer?
|
1R01CA227649-01A1
|
$387,731
|
|
PAPAGIANNAKOPOULOS, THALES
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Ultrasound-based diagnostic and monitoring of bladder cancer treatment with drug released from nanoparticles
|
1R43CA232778-01
|
$295,240
|
|
ASSOULINE, JOE
|
NANOMEDTRIX, LLC
|
|
UAB-MISS WIHS Cohort
|
3U01AI103401-05S1
|
$64,985
|
|
KEMPF, MIRJAM-COLETTE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
Two Compartment Models to Improve Brain Tumor Therapy
|
3R01CA137488-23S1
|
$175,950
|
|
NEUWELT, EDWARD
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Tumor-selective inhibition of DNA repair using pHLIP
|
1F30CA221065-01A1
|
$29,274
|
|
KAPLAN, ALANNA
|
YALE UNIVERSITY
|
|
Tumor-promoting functions of TMPRSS13 in breast cancer progression
|
1R01CA222359-01A1
|
$352,561
|
|
LIST, KARIN
|
WAYNE STATE UNIVERSITY
|
|
Tumor stromal effects of DDR2 in metastasis regulation
|
1R01CA223758-01A1
|
$381,207
|
|
LONGMORE, GREGORY
|
WASHINGTON UNIVERSITY
|
|
Tumor cell-intrinsic STING signaling and IFN-Beta gene regulation in cancer
|
1F30CA232379-01
|
$49,524
|
|
FLOOD, BLAKE
|
UNIVERSITY OF CHICAGO
|
|
Treatment response and microRNA profiles in triple negative breast cancer patients receiving standard chemotherapy (TARMAC)
|
1K43TW010721-01A1
|
$74,124
|
|
NTEKIM, ATARA
|
UNIVERSITY OF IBADAN COLLEGE OF MEDICINE
|
|
Treating Tumoral Hypoxia via Ultrasound-Guided Oxygen Release for Improving Radiation Therapy
|
1R01CA232148-01
|
$676,220
|
|
DAYTON, PAUL
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Translational Molecular and Cellular Imaging Technologies for Prostate Tumor Pathology
|
3R33CA196458-03S1
|
$66,508
|
|
BHARGAVA, ROHIT
|
UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN
|
|
Translational dysregulation of cell fate regulators drives oncogenic growth
|
1F30CA224951-01A1
|
$38,976
|
|
CAI, YI
|
UNIVERSITY OF WASHINGTON
|
|
Transcriptome-wide association study to identify susceptibility genes for colorectal cancer
|
1R37CA227130-01A1
|
$619,625
|
|
GUO, XINGYI
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Transcription repression in prostate cancer
|
3R01CA112226-09S1
|
$80,838
|
|
LOGAN, SUSAN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Training Program in Oncogenic Signals and Chromosome Biology
|
5T32CA108459-13
|
$262,884
|
|
HEYER, WOLF-DIETRICH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Training African Pathologists in Cancer Diagnosis
|
1R13CA232439-01
|
$38,120
|
|
WILSON, MICHAEL
|
AFRICAN STRATEGIES /ADVANCING PATHOLOGY
|
|
Towards Precision Immuno-Oncology: Unraveling the Genomic Determinants and Mechanisms Underlying Immunotherapy Efficacy and Resistance
|
1R35CA232097-01
|
$1,040,850
|
|
CHAN, TIMOTHY
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Towards a Simulation of Cancer Genomes for Benchmarking Structural Variant Algorithms
|
1F31CA232465-01
|
$44,524
|
|
HADI, KEVIN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Tissue-specific tumor suppressor effects of p53
|
3R01CA200256-04S1
|
$78,178
|
|
MANFREDI, JAMES
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
Tissue-specific genetic interactions in cancer
|
1R01CA232372-01
|
$505,643
|
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Three-dimensional organoid models to study breast cancer progression
|
1R37CA232209-01
|
$445,227
|
|
SANT, SHILPA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
Therapeutic Targeting of Casein Kinase-1-delta in Primary and Metastatic Breast Cancer
|
1R01CA223823-01A1
|
$784,837
|
|
DUCKETT, DEREK
|
SCRIPPS FLORIDA
|
Total relevant funding to Alcoholism Research for this search: $476,258
|